SONN Sonnet Biotherapeutics Holdings Inc

USD 1.79 -0.07 -3.763441
Icon

Sonnet Biotherapeutics Holdings Inc (SONN) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.79

-0.07 (-3.76)%

USD 5.59M

9.30K

USD 7.00(+291.06%)

USD 1.85 (+3.35%)

Icon

SONN

Sonnet Biotherapeutics Holdings Inc (USD)
COMMON STOCK | NSD
USD 1.79
0.00 0
Take a Tour

Sonnet Biotherapeutics Holdings Inc (SONN) Stock Forecast

USD 7.00
(+291.06%)

Based on the Sonnet Biotherapeutics Holdings Inc stock forecast from 1 analysts, the average analyst target price for Sonnet Biotherapeutics Holdings Inc is USD 7.00 over the next 12 months. Sonnet Biotherapeutics Holdings Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Sonnet Biotherapeutics Holdings Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Sonnet Biotherapeutics Holdings Inc’s stock price was USD 1.79. Sonnet Biotherapeutics Holdings Inc’s stock price has changed by +1.13% over the past week, -10.50% over the past month and -66.10% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...